# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-25T16:04:29.824731

---

**Idea Fidelity**

The paper substantially diverges from the evaluative strategy articulated in the manifest. While the original idea promised a causal estimate of the EECC’s impact on consumer telecom prices—anticipating a positive treatment effect identified via CS-DiD exploiting staggered transposition—the manuscript instead focuses almost entirely on a methodological critique, concluding that the directive had no measurable effect because the identifying assumptions fail. Key elements from the manifest are missing or never fully developed: there is no in-depth exploration of the welfare costs of regulatory delay, no attempts to quantify consumer surplus losses due to late transposition, and the heterogeneity analysis by pre-treatment concentration (BEREC reports) is absent. The paper therefore has low fidelity to the stated research project.

**Summary**

The paper evaluates the effect of EECC transposition on communications prices using a staggered difference-in-differences design. While traditional TWFE estimates suggest a sizeable price decline, the author shows that heterogeneity-robust CS-DiD estimates shrink toward zero and that pre-trends and placebo outcomes violate the parallel trends assumption, leading to the conclusion that the apparent effect is driven by endogenous timing rather than the directive itself. The paper frames itself as a cautionary tale for researchers using directive transposition as quasi-exogenous variation.

**Essential Points**

1. **Incomplete engagement with the research question:** The original manifest emphasized estimating the cost of regulatory delay and the welfare implications of staggered implementation. The paper instead settles for a null effect and methodological warning without quantifying either the “cost of delay” (e.g., counterfactual pricing paths if all countries transposed on time) or any consumer surplus implications. This leaves the policy question unanswered. The manuscript should either advance the welfare analysis (e.g., by estimating forgone price declines for late transposers) or explicitly justify why the null estimate suffices to speak to regulatory delay costs.

2. **Treatment of comparison groups and parallel trends diagnostics:** The paper concludes that timing is endogenous because of pre-trends and placebo failures, yet the chosen comparison group (never-transposed countries) makes it difficult to separate differential trends from treatment effects. The never-treated group is itself composed of outliers with atypical pricing (e.g., Poland’s rising CPI). More systematic exploration of alternative comparison sets (e.g., matched sets of treated countries with similar pre-trends, synthetic controls, or reweighting) is needed before concluding that identification cannot be salvaged. At present, the conclusion of “selection” rests on diagnostics that use the same suspect comparison group. This is critical for the paper’s argument and must be resolved.

3. **Interpretation of heterogeneous ATTs and placebo outcomes:** The heterogeneity results (positive 2020 cohort, negative 2022 cohort) are interpreted as evidence of selection but could instead reflect real heterogeneous treatment effects (e.g., early reformers already had competitive markets, so further gains were limited). Similarly, the significant placebo effects suggest the treated group differs, but without presenting the raw trends or more granular evidence it is hard to rule out alternative explanations such as balancing differences in CPI measurement. The paper should more carefully explain why the observed heterogeneity is inconsistent with any plausible treatment effect and document the magnitude of pre-existing differences in the outcome and covariates to substantiate claims of endogenous timing.

**Suggestions**

- **Return to the welfare question:** To align with the original motivation, consider computing the implied consumer surplus gains (or foregone gains) under the scenario that all member states had transposed on schedule. Even if the causal effect is negligible, documenting the counterfactual price path required for “cost of delay” estimates would strengthen the policy relevance. For example, you could simulate the path of the communications CPI for late transposers assuming they followed the average trend of early adopters (controlling for observable characteristics) and translate the deviation into monetary terms for households.

- **Deepen the comparison-group strategy:** The failure of never-treated countries to provide a clean counterfactual suggests the need for richer matching or weighting approaches. Consider constructing a synthetic control for each treatment cohort based on pre-treatment CPI trends and relevant covariates (market concentration, income, mobile penetration, regulatory indices). Alternatively, use the doubly robust DiD estimator of \citet{callaway2021} with a reweighted control group that closely matches treated countries in pre-treatment levels and trends. Presenting graphical evidence (e.g., normalized pre-trends by cohort) would help readers judge whether the diagnostic failures truly stem from endogenous timing or simply from an inappropriate comparison group.

- **Expand diagnostics with covariates:** Since the core claim is endogenous timing correlated with telecom market dynamics, include additional covariates such as incumbent concentration, LTE/5G penetration, broadband adoption, or regulatory capacity (from BEREC reports) in the event-study and ATT estimations. Showing that early transposers systematically differ on these dimensions would bolster the story. If such covariates can predict both transposition timing and price trends, it supports the endogenous timing narrative; if not, it challenges it.

- **Clarify the placebo strategy:** The significant placebo effects on food and housing require careful unpacking. Provide the same event-study plots for the placebo outcomes to show the timing and persistence of these “effects.” Additionally, consider using outcomes that are even less likely to be mechanically linked (e.g., education services or non-telecom durable goods) to demonstrate robustness. If the entire CPI basket moves similarly, you may need to model confounders such as inflation shocks or macro stability that could explain the pattern.

- **Revisit inference assumptions:** The paper relies on Callaway-Sant’Anna standard errors clustered at the country level, but with only 29 clusters and large heterogeneity, it would be useful to implement wild bootstrap or permutation inference to ensure results are not driven by a few influential countries. Presenting these robustness checks alongside the main estimates will increase confidence in the null result.

- **Discuss potential measurement issues:** Since transposition is a legal act, the economic implementation might lag, as you note. Consider constructing a complementary measure of “effective enforcement” (e.g., timing of NRA decisions, pricing regulations, or competition cases) to see if those correlate with consumer prices. Even if the initial findings remain null, documenting the lag between legal transposition and regulatory practice helps explain the interpretation of the results.

- **Reframe as a methodology paper if warranted:** If the causal identification cannot be salvaged despite these efforts, reframe the contribution around methodological lessons, emphasizing the risks of using directive transposition timing and proposing guidelines for future researchers (e.g., always pairing transposition timing with rich pre-trend diagnostics and multiple comparison groups). Doing so would align the paper with the evidence it actually presents.

By addressing these points, the paper would better align with its initial policy motivation and provide a clearer, more convincing argument about the limitations and potential pitfalls of using directive transposition for causal inference.
